A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about ...

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

A new Covid-19 variant, officially known as NB.1.8.1 and nicknamed Nimbus, is now the most common strain in the US, according ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Coronavirus cases may surge in the coming weeks, as they have every summer since the pandemic began five years ago, experts ...

Two brothers, Norayr and Vazrik Madadi, have been charged with misappropriating over $2.7 million in COVID-19 relief funds, ...

Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Childhood cancer survivors have a lower risk for registered COVID-19 infection but a higher risk for severe COVID-19, ...